Case report: Invasive aspergillosis successfully treated with voriconazole without recurrence during subsequent bone marrow transplantation.
Invasive aspergillosis is an important cause of morbidity and mortality among immunosuppressed oncology patients. We report a 17-year-old patient with a T cell acute lymphocytic leukemia and invasive aspergillosis treated with voriconazole who remained infection-free during bone marrow transplant.